Certificate of Analysis
| Product Name: | JBJ-09-063 |
| Catalog Number: | M21081 |
Physical and Chemical Properties
| Formula: | C31H29FN4O3S |
| Molecular Weight: | 556.65 |
| Solubility: | N/A |
| Storage: |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Chemical Structure: |  |
Analytical Data
| HPLC: | Shows Min >99% purity |
| H-NMR: | Consistent with structure |
Product Information
| Description: | JBJ-09-063 is an oral allogenic epidermal growth factor inhibitor currently in preclinical development for the study of non-small cell lung cancer (NSCLC) with epidermal growth factor L858R mutations. |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |